Displaying 13 - 24 of 26
Metabolism, Alcohol & Toxicity
6

Perspectum: Advances in non-invasive imaging for NAFLD / NASH - ILC 2022

View
Metabolism, Alcohol & Toxicity
6

Perspectum: Advances in non-invasive imaging for NAFLD / NASH - ILC 2022

View
Metabolism, Alcohol & Toxicity
6

Perspectum: Advances in non-invasive imaging for NAFLD / NASH - ILC 2022

View
Metabolism, Alcohol & Toxicity
6

Perspectum: Advances in non-invasive imaging for NAFLD / NASH - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Liver Tumours
5

Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022

View
Liver Tumours
5

Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022

View
Liver Tumours
5

Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022

View
Displaying 13 - 24 of 26